CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION

Side Effects & Adverse Event Reports


View Chart Data

118.5K

Adverse Events

1.1M

Side Effects

1998

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION.

Understanding the potential Side Effects and Adverse Events of CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION?

    SymPedia shows CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION adverse event reports for 118,546.

  • How many side effects have been reported for CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION?

    SymPedia shows CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION side effect reports for 1,086,995.

  • What year does the CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION reporting data start?

    SymPedia reporting data on this page starts in 1998.

  • What years are included in the yearly chart for CAPITAL AND CODEINE 120 MG / 12 MG IN 5 ML ORAL SUSPENSION?

    SymPedia yearly chart data on this page covers 1998 to 2025.